Is the D543N polymorphism of the SLC11A1/NRAMP1 gene associated with treatment failure in male patients with pulmonary tuberculosis?
In our male population, the presence of the D543N polymorphism of SLC11A1 is a risk factor for treatment failure. This finding should be confirmed in other populations.
These results suggest that CSF Ng is a novel AD biomarker that may be used to monitor synaptic degeneration, and correlates with the rate of cognitive decline in prodromal AD.